Triple

T17093446
Position Surface form Disambiguated ID Type / Status
Subject NewLink Genetics E414780 entity
Predicate developed P73 FINISHED
Object indoximod
Indoximod is an investigational small-molecule immunotherapy drug that modulates the IDO pathway to enhance anti-tumor immune responses in cancer treatment.
E1249864 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: indoximod | Statement: [NewLink Genetics, developed, indoximod]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: indoximod
Context triple: [NewLink Genetics, developed, indoximod]
  • A. Ripatransone
    Ripatransone is a historic hilltop town in Italy’s Marche region, known for its medieval architecture, panoramic views, and well-preserved old center.
  • B. Vimodrone
    Vimodrone is a municipality in the Metropolitan City of Milan in northern Italy, known as a residential and industrial suburb within the Milan urban area.
  • C. Kotramide
    Kotramide was a medieval Armenian noblewoman known primarily as the wife of King Ashot I Bagratuni, the first king of the Bagratid Kingdom of Armenia.
  • D. COX-2
    COX-2 is an inducible cyclooxygenase enzyme involved in inflammation and pain by catalyzing the formation of prostaglandins from arachidonic acid.
  • E. Eskazole
    Eskazole is a brand name for albendazole, an antiparasitic medication used to treat a variety of worm infections in humans.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: indoximod
Triple: [NewLink Genetics, developed, indoximod]
Generated description
Indoximod is an investigational small-molecule immunotherapy drug that modulates the IDO pathway to enhance anti-tumor immune responses in cancer treatment.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: indoximod
Target entity description: Indoximod is an investigational small-molecule immunotherapy drug that modulates the IDO pathway to enhance anti-tumor immune responses in cancer treatment.
  • A. Ripatransone
    Ripatransone is a historic hilltop town in Italy’s Marche region, known for its medieval architecture, panoramic views, and well-preserved old center.
  • B. Vimodrone
    Vimodrone is a municipality in the Metropolitan City of Milan in northern Italy, known as a residential and industrial suburb within the Milan urban area.
  • C. Kotramide
    Kotramide was a medieval Armenian noblewoman known primarily as the wife of King Ashot I Bagratuni, the first king of the Bagratid Kingdom of Armenia.
  • D. COX-2
    COX-2 is an inducible cyclooxygenase enzyme involved in inflammation and pain by catalyzing the formation of prostaglandins from arachidonic acid.
  • E. Eskazole
    Eskazole is a brand name for albendazole, an antiparasitic medication used to treat a variety of worm infections in humans.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886cfc8e88190b05ba466edd35591 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3dbfb89348190942984037bd3bd2e completed April 18, 2026, 7:31 p.m.
NED1 Entity disambiguation (via context triple) batch_6a012eec0d5c8190806e756aae848ba2 completed May 11, 2026, 1:20 a.m.
NEDg Description generation batch_6a012f7f8b148190914b0d7cfb2d5c5c completed May 11, 2026, 1:23 a.m.
NED2 Entity disambiguation (via description) batch_6a012ffb67d4819099ec8d668cb590c9 completed May 11, 2026, 1:25 a.m.
Created at: April 10, 2026, 5:35 a.m.